Yes. Leronlimab stops the signal to recruit more fighters to the Cytokine storm. Lenzilumab reduces GM-CSF which builds the fighters. Elevated GM-CSF is only present in 25% of sever patients.

Elevated cytokines and RANTES is present in 100% of severe patients